Edesa Biotech, Inc. (EDSA)
NASDAQ: EDSA · Real-Time Price · USD
2.670
+0.020 (0.75%)
At close: Oct 15, 2026, 4:00 PM EDT
2.650
-0.020 (-0.75%)
After-hours: Oct 15, 2026, 7:30 PM EDT

Edesa Biotech Ratios and Metrics

Millions USD. Fiscal year is Oct - Sep.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
361714131498
Market Cap Growth
101.94%20.29%8.40%-6.42%-85.44%26.16%
Enterprise Value
2614127190
Last Close Price
2.672.474.454.426.4551.66

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Forward PE
-0.880.880.8856.67-
PB Ratio
64.471.407.291.891.527.49
P/TBV Ratio
-14.32-2.742.009.16

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Debt / Equity Ratio
--0.010.010.000.01
Net Debt / Equity Ratio
-1.17-0.87-0.51-0.75-0.75-0.59
Net Debt / EBITDA Ratio
0.711.390.150.580.390.33
Net Debt / FCF Ratio
1.161.470.210.790.580.57
Quick Ratio
2.7010.600.713.293.907.64
Current Ratio
2.7610.680.913.534.258.29
Return on Equity (ROE)
-122.93%-99.57%-136.66%-101.88%-156.34%-120.39%
Return on Assets (ROA)
-66.43%-57.02%-69.02%-56.33%-87.78%-116.79%
Return on Capital Employed (ROCE)
-166.00%-63.50%-354.10%-130.50%-194.70%-180.40%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Earnings Yield
-39.09%-41.34%-42.70%-62.82%-123.19%-13.64%
FCF Yield
-24.69%-42.12%-33.84%-49.78%-86.24%-13.98%
Buyback Yield / Dilution
-72.33%-77.54%-11.84%-36.37%-21.50%-40.32%
SEC Filings: 10-K · 10-Q